Literature DB >> 28531802

Anti-inflammatory and antioxidant effect of cerium dioxide nanoparticles immobilized on the surface of silica nanoparticles in rat experimental pneumonia.

Z Serebrovska1, R J Swanson2, V Portnichenko3, A Shysh3, S Pavlovich3, L Tumanovska3, A Dorovskych4, V Lysenko5, V Tertykh6, Y Bolbukh6, V Dosenko3.   

Abstract

A massage with the potent counter-inflammatory material, cerium dioxide nanoparticles, is promising and the antioxidant properties of CeO2 are considered the main, if not the only, mechanism of this action. Nevertheless, the elimination of ceria nano-particles from the organism is very slow and there is a strong concern for toxic effect of ceria due to its accumulation. To overcome this problem, we engineered a combined material in which cerium nanoparticles were immobilized on the surface of silica nanoparticles (CeO2 NP), which is shown to be easily removed from an organism and could be used as carriers for nano-ceria. In our study particle size was 220±5nm, Zeta-potential -4.5mV (in water), surface charge density -17.22μC/cm2 (at pH 7). Thirty-six male Wistar rats, 5 months old and 250-290g were divided into four groups: 1) control; 2) CeO2 NP treatment; 3) experimental pneumonia (i/p LPS injection, 1mg/kg); and 4) experimental pneumonia treated with CeO2 NP (4 times during the study in dosage of 0.6mg/kg with an orogastric catheter). Gas exchange and pulmonary ventilation were measured four times: 0, 1, 3 and 24h after LPS injection in both untreated and CeO2 NP-treated animals. The mRNA of TNF-α, Il-6, and CxCL2 were determined by RT-PCR. ROS-generation in blood plasma and lung tissue homogenates were measured by means of lucigenin- and luminol-enhanced chemiluminescence. Endotoxemia in the acute phase was associated with: (1) pathological changes in lung morphology; (2) increase of ROS generation; (3) enhanced expression of CxCL2; and (4) a gradual decrease of VO2 and VE. CeO2 NP treatment of intact animals did not make any changes in all studied parameters except for a significant augmentation of VO2 and VE. CeO2 NP treatment of rats with pneumonia created positive changes in diminishing lung tissue injury, decreasing ROS generation in blood and lung tissue and decreasing pro-inflammatory cytokine expression (TNF-α, Il-6 and CxCL2). Oxygen consumption in this group was increased compared to the LPS pneumonia group. In our study we have shown anti-inflammatory and antioxidant effects of CeO2 NP. In addition, this paper is the first to report that CeO2 NP stimulates oxygen consumption in both healthy rats, and rats with pneumonia. We propose the key in understanding the mechanisms behind the phenomena lies in the property of CeO2 NP to scavenge ROS and the influence of this potent antioxidant on mitochondrial function. The study of biodistribution and elimination of СеО2NP is the purpose of our ongoing study.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anti-inflammatory; Antioxidant; CINC-2; Cerium dioxide nanoparticles; Il-6; Metabolism; Oxygen consumption; Silica nanoparticles; TNF-α

Mesh:

Substances:

Year:  2017        PMID: 28531802     DOI: 10.1016/j.biopha.2017.05.064

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

1.  Antioxidant and toxicity studies of biosynthesized cerium oxide nanoparticles in rats.

Authors:  Mohammad Bagher Khorrami; Hamid Reza Sadeghnia; Alireza Pasdar; Majid Ghayour-Mobarhan; Bamdad Riahi-Zanjani; Alireza Hashemzadeh; Mohammad Zare; Majid Darroudi
Journal:  Int J Nanomedicine       Date:  2019-04-26

Review 2.  Metal Oxide Nanoparticles in Therapeutic Regulation of Macrophage Functions.

Authors:  Marina S Dukhinova; Artur Y Prilepskii; Alexander A Shtil; Vladimir V Vinogradov
Journal:  Nanomaterials (Basel)       Date:  2019-11-16       Impact factor: 5.076

Review 3.  Nanomedicine-Based Therapeutics to Combat Acute Lung Injury.

Authors:  Youbin Cui; Wanguo Liu; Shuai Bian; Hongfei Cai; Chunsheng Xiao
Journal:  Int J Nanomedicine       Date:  2021-03-18

Review 4.  Applications of nanomaterials in COVID-19 pandemic.

Authors:  Mei-Fang Xiao; Chang Zeng; Shao-Hui Li; Fu-Lai Yuan
Journal:  Rare Metals       Date:  2021-09-15       Impact factor: 4.003

5.  Phosphorus dendron nanomicelles as a platform for combination anti-inflammatory and antioxidative therapy of acute lung injury.

Authors:  Jin Li; Liang Chen; Changsheng Li; Yu Fan; Mengsi Zhan; Huxiao Sun; Serge Mignani; Jean-Pierre Majoral; Mingwu Shen; Xiangyang Shi
Journal:  Theranostics       Date:  2022-04-11       Impact factor: 11.600

6.  The effect of cerium oxide on lung injury following lower extremity ischemia-reperfusion injury in rats under desflurane anesthesia.

Authors:  Aycan Ozdemirkan; Aysegul Kucuk; Isin Gunes; Mustafa Arslan; Aydin Tuncay; Volkan Sivgin; Saban C Sezen; Hakan Boyunaga
Journal:  Saudi Med J       Date:  2021-11       Impact factor: 1.422

7.  Nursing research on a new silver-based antibacterial agent for pneumonia.

Authors:  Jiannan Wu; Dan Cao; Laifang Xu
Journal:  Appl Nanosci       Date:  2022-09-22       Impact factor: 3.869

8.  Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy.

Authors:  Rongtao Zhang; Siqiong Wu; Qian Ding; Qingze Fan; Yan Dai; Shiwei Guo; Yun Ye; Chunhong Li; Meiling Zhou
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

9.  Insights from nanotechnology in COVID-19 treatment.

Authors:  Zhongmin Tang; Xingcai Zhang; Yiqing Shu; Ming Guo; Han Zhang; Wei Tao
Journal:  Nano Today       Date:  2020-11-04       Impact factor: 20.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.